Search for a funded project
Development of GaN process on silicon substrate for millimetre wave applications – SATELLITE
Gallium nitride based High Electron Mobility Transistors (HEMTs) offer the unique possibility to design and fabricate microwave power devices giving outstanding performance at high frequency because the microwave power density is several order of magnitude higher than those obtained on GaAs or InP b
Development of Near-Infrared Mediated Photocatalytic Nanocomposites for the Treatment of Turbid Wastewaters – UpPhotoCat
Polycyclic aromatic hydrocarbons (PAHs) consisting of several fused benzene rings are found as products of the incomplete combustion of hydrocarbons (e.g. forest fire) as well as in flowback and produced water from Coal bed methane (CBM) and shale gas extraction process. These two processes are wide
Development of New Selective Materials for the Adsorption of Nitrogen Oxides – NOA
The operation chosen is the gas-solid adsorption more effective than the catalysis at low temperature. The regeneration of the process will take place in time and deported from the vehicle. The first screening of materials by molecular modeling has allowed us to extract three candidates with high po
Development of a Real Time Monitoring non invasive In Vivo Mass Spectrometry System for Diagnostic: REALITY'MS – REALITY'MS
The challenge of the SpiderMass project is to develop an instrument for allowing the analysis in-vivo and in real-time in the surgical room. This is a main issue with regards to the importance of the quality of the surgery on patient’s outcome and survival. Currently, none of the existing technologi
Development of a new Biocontrol Agent to reduce AflaToxin B1 contamination in maize crops for sustainable agriculture – DEBAAT
This project aims to develop the first biocontrol agent (BCA) from bacterial origin to effectively control aflatoxin B1 (AFB1) contamination of maize crops. AFB1 is a human carcinogenic mycotoxin produced by Aspergillus flavus, a filamentous fungus, emerging on maize in Europe and in France in respo
Development of a prevention tool through resource optimization following the early identification of post-traumatic stress disorder. – RESTORE
The objective of the RESTORE project is to develop a prevention tool for military personnel identified as being at risk of post-traumatic stress disorder (PTSD) through the D STRESS tool, the initial project from which this request originates. It is essential to prevent PTSD, a common disorder amon
Development of an ultra-thin monitor for charged particle beams – PEPITES
Proton therapy is a cancer-fighting technique using proton beams, which allows better preservation of healthy tissue than conventional radiotherapy while remaining effective in destroying tumours. However, during the treatment, the correct delivery of the dose requires continuous and precise measure
Development of atmospheric plasma Enhanced SPatial ATomiC layer deposition (SALD) for application to silicon Heterojunction solar cells – DESPATCH
Si solar cells are the main photovoltaic technology being used nowadays. While efficiencies reached are approaching the theoretic maximum, cost is still an issue to be fully competitive with fossil fuels. A new technology called Silicon Heterojunction Solar (HET) Cells has been developed in which th
Development of grafting processes in supercritical CO2 for microsystems – PROGRESS
The MEMS sector develops promising new applications in the field of life, such as micro and nano-sensors, analyzers and lab-on-chips. Their manufacture requires realizing organic layers deposition with controlled nanometer-range thickness, in order to obtain functional surfaces (sensitive part of th
Development of nanobody-based vectors that cross the blood brain barrier via receptor-mediated transcytosis for brain delivery of imaging or therapeutic agents – NANOVECTOR
Central Nervous System (CNS) diseases are the world’s leading cause of disability and affect over 450 million people, causing disability and suffering. The total annual cost of brain disorders in Europe is in the range of €500-700 billion/year. CNS disease treatments, though essentially palliative,
